These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1862735)

  • 1. Validation criteria for panic disorder as a nosological entity.
    Rosenberg R; Ottosson JO; Bech P; Mellergård M; Rosenberg NK
    Acta Psychiatr Scand Suppl; 1991; 365():7-17. PubMed ID: 1862735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Panic disorder--a new diagnosis. Clinical picture and treatment].
    Rosenberg R
    Ugeskr Laeger; 1993 Apr; 155(16):1189-94. PubMed ID: 8497950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
    Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M; Lorentzen K; Bech P; Ottosson JO; Rosenberg R
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M; Lecrubier Y; Maier W; Buller R; Rosenberg R; Hippius H
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alprazolam on depression in panic disorder.
    Melvin JA; Lydiard RB; Crowe CM; Laraia MT; Fossey MD; Ballenger JC
    J Clin Psychopharmacol; 1991 Apr; 11(2):145-6. PubMed ID: 2056142
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK; Mellergård M; Rosenberg R; Beck P; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():33-8. PubMed ID: 1862732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Cowley DS; Dager SR; Roy-Byrne PP; Avery DH; Dunner DL
    Biol Psychiatry; 1991 Jul; 30(1):49-56. PubMed ID: 1892962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Deltito JA; Argyle N; Buller R; Nutzinger D; Ottosson JO; Brandon S; Mellergard M; Shera D
    Compr Psychiatry; 1991; 32(2):120-9. PubMed ID: 2022110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone suppression test in patients with panic disorder and secondary depression.
    Bueno JA; Sabanes F; Gascon J; Gasto C; Salamero M
    Arch Gen Psychiatry; 1984 Jul; 41(7):723-4. PubMed ID: 6732433
    [No Abstract]   [Full Text] [Related]  

  • 19. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    Albus M; Maier W; Shera D; Bech P
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):96-102. PubMed ID: 2149655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R; Maier W; Goldenberg IM; Lavori PW; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(3):163-8. PubMed ID: 1827602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.